DAVID GRANOVSKY

PFIZER BUYS INTO ADULT/REPAIR STEM CELL COMPANY ATHERSYS

In BUSINESS OF STEM CELLS, VICTORIES & SUCCESS STORIES on December 21, 2009 at 1:18 pm

PFIZER BUYS STEM CELL COMPANY ATHERSYS & Acquires Stem-Cell Therapy Product MulitStem

By ANDREW POLLACK

Published: December 21, 2009 – Pfizer said Sunday that it was buying the rights to a somewhat controversial cell therapy from Athersys, a biotechnology company — a sign of big pharmaceutical companies’ growing interest in (ADULT or REPAIR)  stem cells.

Why is this controversial? There are no embryos involved.  These are adult or repair stem cells.  There are thousands of clinical trials and tens of thousands of scholarly papers showing their safety and efficacy.  If a new cancer drug comes out that is not through all stages of clinical trials it is not controversial; why is this? -dg

Athersys’s cells, derived from human bone marrow (these are Adult or Repair Stem Cells, not embryonic – dg), have not yet been tested in people with inflammatory bowel disease, a term that encompasses ulcerative colitis and Crohn’s disease. But the product, called MultiStem, is in early human testing as a treatment for heart attacks and for cancer patients receiving bone marrow transplants.

Pfizer will have the rights to develop Athersys’s cells to treat inflammatory bowel diseases, the companies are expected to announce on Monday.

Irritable Bowel Syndrome + Crohn's Disease Treatment Info

CLICK PICTURE for Irritable Bowel Syndrome, Colitis, Crohn's Disease Treatment Info

STOCK ALERT

Pfizer will pay Athersys $6 million initially and up to $105 million in the future.  Athersys [ NASDAQ:ATHX ] soared as high as $3.95 today on the news and has leveled off to $2.80, a 180% gain by noon today.)

via Pfizer Acquires MultiStem, a Therapy Based on Stem Cells – NYTimes.com.

For more info:

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: